Narjust Florez: Discussed the role of FLAURA-2 in the treatment of young patients with EGFR positive lung cancer
Marcelo Corassa, Medical oncologist and Clinical Researcher at Portuguese Beneficence of São Paulo, shared a post by Narjust Florez on X, adding:
“Always a pleasure, Narjust Florez! A shame you were not here in person!”
Quoting Narjust Florez’s post:
“Thank you to my colleagues in Brazil particularly Marcelo Corassa for the invitation to discuss the role of FLAURA-2 in the treatment of young patients with Epidermal Growth Factor Receptor (EGFR) positive lung cancer.
From clinic to Brazil!
Great discussion and insights.”
Source: Marcelo Corassa/X and Narjust Florez/X
Narjust Florez is the Associate Director of the Cancer Care Equity Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer.
She received the 2020 Rising Star award by the LEAD National Conference for women in hematology and oncology. In addition, Dr. Florez founded the Florez Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine, and medical education.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023